Christopher Rhodes to Genome-Wide Association Study
This is a "connection" page, showing publications Christopher Rhodes has written about Genome-Wide Association Study.
Connection Strength
0.427
-
Shared and Distinct Genomics of Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Embolism. Am J Respir Crit Care Med. 2024 06 15; 209(12):1477-1485.
Score: 0.132
-
Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Lancet Respir Med. 2019 03; 7(3):227-238.
Score: 0.090
-
Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension. Circulation. 2024 Oct 15; 150(16):1268-1287.
Score: 0.034
-
Multi-biobank summary data Mendelian randomisation does not support a causal effect of IL-6 signalling on risk of pulmonary arterial hypertension. Eur Respir J. 2024 Apr; 63(4).
Score: 0.033
-
Mendelian Randomization Study With Clinical Follow-Up Links Metabolites to Risk and Severity of Pulmonary Arterial Hypertension. J Am Heart Assoc. 2024 Mar 19; 13(6):e032256.
Score: 0.032
-
SOX17 Enhancer Variants Disrupt Transcription Factor Binding And Enhancer Inactivity Drives Pulmonary Hypertension. Circulation. 2023 05 23; 147(21):1606-1621.
Score: 0.031
-
Expression Quantitative Trait Locus Mapping in Pulmonary Arterial Hypertension. Genes (Basel). 2020 10 22; 11(11).
Score: 0.026
-
The application of 'omics' to pulmonary arterial hypertension. Br J Pharmacol. 2021 01; 178(1):108-120.
Score: 0.025
-
Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertension. Eur Respir J. 2020 02; 55(2).
Score: 0.024